California § 22949.51. 22949.51. (Added by Stats. 2019, Ch. 140, Sec. 2.)

California Statutes

§ 22949.51. — 22949.51. (Added by Stats. 2019, Ch. 140, Sec. 2.)

California·Code BPC Business and Professions Code - BPC·Div. 8. DIVISION 8. SPECIAL BUSINESS REGULATIONS·Ch. 37. CHAPTER 37. Gene Therapy Kits: Notice

For purposes of this chapter, the following definitions apply:

(a)“Gene therapy” refers to the administration of genetic material to modify or manipulate the expression of a gene product, or to alter the biological properties of living cells, for therapeutic use.

(b)“Gene therapy kit” refers to a product that is sold as a collection of materials for the purpose of facilitating gene therapy experiments, including, but not limited to, a system for the targeted cutting of DNA molecules, such as type II clustered regularly interspaced short palindromic repeats (CRISPR), associated proteins (CRISPR-Cas) systems, including CRISPR-Cas9, as described in Regents of University of California v. Broad Institute, Inc.

(2018)903 F.3d 1286.

Free access — add to your briefcase to read the full text and ask questions with AI

For purposes of this chapter, the following definitions apply:
(a)
“Gene therapy” refers to the administration of genetic material to modify or manipulate the expression of a gene product, or to alter the biological properties of living cells, for therapeutic use.
(b)
“Gene therapy kit” refers to a product that is sold as a collection of materials for the purpose of facilitating gene therapy experiments, including, but not limited to, a system for the targeted cutting of DNA molecules, such as type II clustered regularly interspaced short palindromic repeats (CRISPR), associated proteins (CRISPR-Cas) systems,
including CRISPR-Cas9, as described in Regents of University of California v. Broad Institute, Inc. (2018) 903 F.3d 1286.

California § 22949.51. (22949.51. (Added by Stats. 2019, Ch. 140, Sec. 2.)) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.